These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 23322330)
1. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug. Knežević NŽ; Lin VS Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330 [TBL] [Abstract][Full Text] [Related]
3. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423 [TBL] [Abstract][Full Text] [Related]
4. Magnetic Field-Induced Accentuation of Drug Release from Core/Shell Magnetic Mesoporous Silica Nanoparticles for Anticancer Treatment. Knezević Nikola Z J Nanosci Nanotechnol; 2016 Apr; 16(4):4195-9. PubMed ID: 27451786 [TBL] [Abstract][Full Text] [Related]
5. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy. Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional hybrid materials for combined photo and chemotherapy of cancer. Botella P; Ortega I; Quesada M; Madrigal RF; Muniesa C; Fimia A; Fernández E; Corma A Dalton Trans; 2012 Aug; 41(31):9286-96. PubMed ID: 22555652 [TBL] [Abstract][Full Text] [Related]
7. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy. Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231 [TBL] [Abstract][Full Text] [Related]
8. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles. Kim C; Kim S; Oh WK; Choi M; Jang J Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377 [TBL] [Abstract][Full Text] [Related]
9. Responsive delivery of drug cocktail via mesoporous silica nanolamps. Muhammad F; Guo M; Wang A; Zhao J; Qi W; Guo Y; Zhu G J Colloid Interface Sci; 2014 Nov; 434():1-8. PubMed ID: 25151090 [TBL] [Abstract][Full Text] [Related]
10. Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Chen T; Xu S; Zhao T; Zhu L; Wei D; Li Y; Zhang H; Zhao C ACS Appl Mater Interfaces; 2012 Nov; 4(11):5766-74. PubMed ID: 23043448 [TBL] [Abstract][Full Text] [Related]
11. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Xu Z; Liu S; Kang Y; Wang M Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484 [TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Lu J; Liong M; Zink JI; Tamanoi F Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138 [No Abstract] [Full Text] [Related]
13. Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery. Ma X; Nguyen KT; Borah P; Ang CY; Zhao Y Adv Healthc Mater; 2012 Nov; 1(6):690-7. PubMed ID: 23184818 [TBL] [Abstract][Full Text] [Related]
14. Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform. Zhang Z; Liu C; Bai J; Wu C; Xiao Y; Li Y; Zheng J; Yang R; Tan W ACS Appl Mater Interfaces; 2015 Mar; 7(11):6211-9. PubMed ID: 25707533 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766 [TBL] [Abstract][Full Text] [Related]
16. Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia. Lu F; Popa A; Zhou S; Zhu JJ; Samia AC Chem Commun (Camb); 2013 Dec; 49(97):11436-8. PubMed ID: 24169596 [TBL] [Abstract][Full Text] [Related]
17. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571 [TBL] [Abstract][Full Text] [Related]
18. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin. Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Huang ZR; Hua SC; Yang YL; Fang JY Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells. Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]